Hanno, Japan

Kazuhisa Miyoshi

This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kazuhisa Miyoshi. Retrieved from https://idiyas.com/inventor/kazuhisa-miyoshi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kazuhisa Miyoshi: Innovator in Prostatic Research

Introduction

Kazuhisa Miyoshi is a notable inventor based in Hanno, Japan. He has made significant contributions to the field of medical research, particularly in the area of prostatic health. His innovative work has led to the development of a unique animal model that aids in the understanding and treatment of benign prostatic hyperplasia.

Latest Patents

Miyoshi holds a patent for an "Interstitial prostatism model animal." This invention provides an animal model for prostatic stromal hyperplasia, which is crucial for screening substances that may prevent or treat human benign prostatic hyperplasia. The model is created by implanting the fetal urogenital sinus of a non-human animal, allowing researchers to measure the effects of various test substances on the implanted tissue.

Career Highlights

Kazuhisa Miyoshi is associated with Taiho Pharmaceutical Company Limited, where he continues to advance research in prostatic conditions. His work is characterized by a commitment to improving therapeutic options for patients suffering from benign prostatic hyperplasia.

Collaborations

Miyoshi collaborates with esteemed colleagues such as Nobuyuki Oda and Akihiro Haruno. Their combined expertise enhances the research efforts at Taiho Pharmaceutical Company Limited.

Conclusion

Kazuhisa Miyoshi's contributions to medical research, particularly through his innovative patent, have the potential to significantly impact the treatment of prostatic conditions. His work exemplifies the importance of innovation in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…